Results 141 to 150 of about 19,438 (226)

Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of Pseudomonas and Anthrax Toxins. [PDF]

Toxins (Basel)
Misra R, Gupta R, Nayyar N, Baweja R, Sharma V, Singh Y, Baweja R.   +6 more
europepmc   +1 more source

<i>Pseudomonas aeruginosa</i> Pathogenicity and Its Interaction with Other Microorganisms During the Skin Wound Healing Process. [PDF]

Int J Mol Sci
Yamberla I, Pupiales C, Chiliquinga AJ, Sulca-Villamarín T, Plasencia A, Cabrera Aulestia F, Díaz RF, Caicedo A, Barba PM.   +8 more
europepmc   +1 more source

The presence of exotoxin genes and biofilm production in carbapenem-resistant <i>Pseudomonas aeruginosa</i> clinical isolates. [PDF]

Germs
Thabit AG, Sediek MN, Mohamed MSE.
europepmc   +1 more source

Clinical application of benzathine penicillin G as secondary prophylaxis and vaccines for patients with acute rheumatic fever and rheumatic heart disease: A comprehensive review. [PDF]

Int J Cardiol Congenit Heart Dis
Nibret G, Messelu MA, Dagne A.
europepmc   +1 more source

Caps & Capes - Volume V Issue III [PDF]

, 1963

core   +1 more source

Stem cell differentiation in Hydra [PDF]

, 1975
David, Charles N., Schlessinger, David
core   +1 more source

Glycoengineering the Pseudomonas exotoxin A for multi-sequon integration and enhanced bioconjugation efficiency by PglS. [PDF]

Glycobiology
Knoot CJ, Pomper N, Robinson LS, Harding CM.   +3 more
europepmc   +1 more source

Advances in Nanoparticles as Vaccine Adjuvants. [PDF]

Vaccines (Basel)
Ahmadivand S, Gomez-Casado E.
europepmc   +1 more source

Taming Bacterial Toxins into an Anticancer Platform. [PDF]

Biochem Biophys Res Commun
Yang C, Chen C.
europepmc   +1 more source

Exploring the ER channel protein Sec61: recent advances in pathophysiological significance and novel pharmacological inhibitors. [PDF]

Front Pharmacol
Xin J, Yin K, Li S, Gu P, Shao S.
europepmc   +1 more source